Nordnet One Rohkea vs UBS Lux Equity Fund Biotech USD

Nordnet One Rohkea vs UBS Lux Equity Fund Biotech USD

1. Nordnet One Rohkea

  • Security

    Nordnet One Rohkea EUR

  • Fee

    0.49%

  • ISIN

    SE0017832421

  • Holdings

    10

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 15 holdings in Nordnet One Rohkea, where the largest holding is Nordnet USA Indeksi (16.68), followed by Nordnet Maailma Indeksi (16.17) and SEB Global Exposure IC EUR (16.07). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Nordnet One Rohkea and UBS Lux Equity Fund Biotech USD.

Nordnet One Rohkea UBS Lux Equity Fund Biotech USD
1. Nordnet USA Indeksi
Ireland
16.68 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Nordnet Maailma Indeksi
Ireland
16.17 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. SEB Global Exposure IC EUR
Luxembourg
16.07 %
3. Moderna Inc
9.21 %
4. Nordnet Teknologia Indeksi
Ireland
11.12 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Nordnet Eurooppa Indeksi
Ireland
10.62 %
5. AbbVie Inc
USA
5.53 %
6. Nordnet Kehittyvät Markkinat Indeksi
Ireland
8.31 %
6. Gilead Sciences Inc
USA
4.66 %
7. Nordnet Suomi Indeksi
Sweden
5.38 %
7. Amgen Inc
4.3 %
8. Nordnet Danmark Indeks B
Sweden
4.91 %
8. BioNTech SE
4.13 %
9. Nordnet Sverige Index
Sweden
4.84 %
9. Karuna Therapeutics Inc
3.75 %
10. Nordnet Norge Indeks
Sweden
4.76 %
10. Royalty Pharma Plc
3.37 %

The list of fund holdings was last updated on June 5, 2025.